logo
Top Stories
56
45
google-hudson-square-121718-lg.jpg

Alphabet Inc.'s (GOOG, GOOGL) Google said Monday that it will expand its presence in New York City by investing over $1 billion in capital requirements to establish a new campus known as Google Hudson Square. Google noted that its investment in New...

nahb-121718-lg.jpg

After reporting a sharp pullback in U.S. homebuilder confidence in the previous month, the National Association of Home Builders released a report on Monday unexpectedly showing a continued deterioration in confidence in the month of December.

donald-trump2-121718-lg.jpg

Just days ahead of the Federal Reserve's latest monetary policy decision, President Donald Trump has continued to lash out at the central bank's plan to gradually raise interest rates. Trump called it "incredible" the Fed is considering another interest...

wallstreet4-061518_17dec18-lg.jpg

Stocks have shown a significant rebound over the course of the trading day on Monday after coming under considerable pressure early in the session. The major averages have bounced well off their worst levels of the day.

trump-fort-drum-121018.jpg Despite recently calling this year's $716 billion defense budget "crazy," President Donald Trump reportedly plans to ask for a sharp increase in military spending next fiscal year.
wallstreet-up-032918_10dec18.jpg After moving sharply lower in morning trading, stocks staged a substantial turnaround over the course of the trading session on Monday. The major averages climbed well off their worst levels of the day and into positive territory.
pharmaup-dec10.jpg The following are some of today's top gainers in the pharma/biotech sector.
asian-mixed_10dec18.jpg Asian stock markets are mixed on Tuesday after U.S. stocks managed a late-stage recovery in a volatile session overnight. Worries about global economic growth, U.S.-China trade tensions, and political turmoil in Britain after Prime Minister Theresa May delayed a key vote on Brexit weighed on investor sentiment. The Australian market is modestly higher, while the Japanese market is declining.
Read More
donald-trump2-121718.jpg Just days ahead of the Federal Reserve's latest monetary policy decision, President Donald Trump has continued to lash out at the central bank's plan to gradually raise interest rates. Trump called it "incredible" the Fed is considering another interest rate hike in a post on Twitter on Monday.
Read More
alexander-lamar121718.jpg Republican Senator Lamar Alexander, R-Tenn., announced Monday he will not seek re-election to a fourth term in the Senate in 2020. "The people of Tennessee have been very generous, electing me to serve more combined years as Governor and Senator than...
Read More
aphria-dec04.jpg
Shares of Aphria Inc. tumbled more than 23 percent in Tuesday's regular trading on the New York Stock Exchange after a short seller called the Canada-based medical cannabis company a "black hole" and alleged that the company's recent Latin American acquisitions appeared to be largely worthless. In response to the allegations, Aphria said it believes the short-seller report is malicious.
Read More
The Swiss stock market weakened along with the rest of Europe at the start of the new trading week. Lingering concerns about global economic growth as well as continued uncertainty about trade between the U.S. and China weighed on investor sentiment. The dollar also weakened ahead of the Federal Reserve's...
linkedinblockchain-dec17.jpg
Blockchain and artificial intelligence are the fastest-growing job categories, according to a report published by LinkedIn, the networking platform for professionals. Blockchain Developer is topping the list amid the ongoing hype around blockchain and cryptocurrency. As per the Emerging Jobs Report for 2018, the U.S has seen a surge in demand for people with blockchain development skills.
Read More
A summary of some of the widely followed stories on cryptocurrency and blockchain during the past 24 hours. Read More
After 7 years of absence, asthma inhaler Primatene Mist, developed by Amphastar Pharmaceuticals, is reentering the market with renewed features. Read More
Eli Lilly and Co. (LLY) said Monday that Taltz, or ixekizumab, met the primary and all major secondary endpoints in the Phase 3b/4 SPIRIT-H2H study, which evaluated the efficacy and safety of Taltz versus Humira, or adalimumab, in patients with active... Read More
Technology is a double-edged sword, and it is even truer in the case of gene editing, a revolutionary technique that involves inserting, replacing or removing DNA of a human embryo.In this week's "Did you know" column, we bring you news about the world's first gene-edited babies, the top influential films and directors, and the association between cannabis abstinence and memory improvement. Read More
culedger-r3-121718.jpg Blockchain consortium CULedger joined the New York-based blockchain consortium R3's global blockchain ecosystem of more than 200 of the world's largest financial services firms, technology companies, central banks, regulators, and trade associations working together on R3's Corda enterprise-grade blockchain platform.
Read More
Follow RTT
Economic Calendar
DateIndicatorPeriodCountry
12/17/18 10:30CB Leading IndexOCT Australia
12/17/18 10:30CB Coincidence IndexOCT Australia
12/17/18 10:0NAHB/Wells Fargo Housing Market IndexDEC United States
12/17/18 9:0Consumer Confidence IndexDEC Belgium
12/17/18 9:0CB Leading IndexNOV India
12/17/18 9:0CB Coincidence IndexNOV India
View All
FDA Calendar
Event DateSymbolDrug NameEvent Name
03/14/19AERIRoclatan (NDA)FDA decision on Roclatan for patients with open-angle glaucoma, retina diseases
03/12/19RHHBYTecentriq (sBLA)FDA decision on Tecentriq in Combination with Abraxane for Initial Treatment of People with PD-L1-Positive, Metastatic Triple-Negative Breast Cancer
02/25/19BHC, BHC.TO Loteprednol etabonate ophthalmic gel (NDA)FDA decision on Loteprednol etabonate ophthalmic gel for post-operative inflammation and pain following ocular surgery
02/18/19ALXNALXN1210 (BLA)FDA decision on ALXN1210 for the treatment of patients with paroxysmal nocturnal hemoglobinuria
02/13/19MTFBIclaprim (NDA)FDA decision on Iclaprim for acute bacterial skin and skin structure infections
View All